title: Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.
authors.affiliation: Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
authors.forename: N K
authors.initials: NK
authors.lastname: Cheung
authors.forename: G
authors.initials: G
authors.lastname: Heller
authors.forename: B H
authors.initials: BH
authors.lastname: Kushner
authors.forename: L
authors.initials: L
authors.lastname: Burch
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Reilly
mesh_terms: D000367:Age Factors; D000704:Analysis of Variance; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007223:Infant; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D012044:Regression Analysis